Heteroresistance: a concern of increasing clinical significance?

被引：93

作者：

Falagas, M. E. ^{[1
,2
,3
]}

Makris, G. C. ^{[1
]}

Dimopoulos, G. ^{[1
,4
]}

Matthaiou, D. K. ^{[1
]}

机构：

[1] Alfa Inst Biomed Sci, Maroussi 15123, Greece

[2] Tufts Univ, Sch Med, Dept Med, Boston, MA 02111 USA

[3] Henry Dunant Hosp, Dept Med, Athens, Greece

[4] Univ Athens, Univ Hosp Attikon, Dept Crit Care, Athens, Greece

来源：

CLINICAL MICROBIOLOGY AND INFECTION | 2008年 / 14卷 / 02期

关键词：

antibiotic resistance; clinical implications; glycopeptides; heteroresistance; Staphylococcus aureus; vancomycin;

D O I：

10.1111/j.1469-0691.2007.01912.x

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

Recent studies have focused on issues related to heteroresistance, including its definition, methods of detection and frequency. Most such studies have reported data concerning infections caused by Staphylococcus aureus, but the clinical significance of heteroresistance is unclear. Six studies have described infections caused by S. aureus strains that were heteroresistant to vancomycin, with two suggesting an association between the emergence of heteroresistance and treatment failure or mortality, and four suggesting no such association. Further studies are required to evaluate the clinical implications of heteroresistance in an era in which rates of antimicrobial resistance are increasing alarmingly worldwide.

引用

页码：101 / 104

页数：4

共 23 条

[1] Heteroresistance to vancomycin in Enterococcus faecium [J].

Alam, MR ;

Donabedian, S ;

Brown, W ;

Gordon, J ;

Chow, JW ;

Zervos, MJ ;

Hershberger, E .

JOURNAL OF CLINICAL MICROBIOLOGY, 2001, 39 (09) :3379-3381

[2] Combination effect of vancomycin and β-lactams against a Staphylococcus aureus strain, Mu3, with heterogeneous resistance to vancomycin [J].

Aritaka, N ;

Hanaki, H ;

Cui, LZ ;

Hiramatsu, K .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (04) :1292-1294

[3] Vancomycin in surgical infections due to meticillin-resistant Staphylococcus aureus with heterogeneous resistance to vancomycin [J].

Ariza, J ;

Pujol, M ;

Cabo, J ;

Peña, C ;

Fernández, N ;

Liñares, J ;

Ayats, J ;

Gudiol, F .

LANCET, 1999, 353 (9164) :1587-1588

[4] Prevalence, molecular epidemiology, and clinical significance of heterogeneous glycopeptide-intermediate Staphylococcus aureus in liver transplant recipients [J].

Bert, F ;

Clarissou, J ;

Durand, F ;

Delefosse, D ;

Chauvet, C ;

Lefebvre, P ;

Lambert, N ;

Branger, C .

JOURNAL OF CLINICAL MICROBIOLOGY, 2003, 41 (11) :5147-5152

[5] Virulence of antibiotic-resistant Salmonella typhimurium [J].

Björkman, J ;

Hughes, D ;

Andersson, DI .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (07) :3949-3953

[6] Effect of aminoglycoside and β-lactam combination therapy versus β-lactam monotherapy on the emergence of antimicrobial resistance:: A meta-analysis of randomized, controlled trials [J].

Bliziotis, IA ;

Samonis, G ;

Vardakas, KZ ;

Chrysanthopoulou, S ;

Falagas, ME .

CLINICAL INFECTIOUS DISEASES, 2005, 41 (02) :149-158

[7] Mutant selection window hypothesis updated [J].

Drlica, Karl ;

Zhao, Xilin .

CLINICAL INFECTIOUS DISEASES, 2007, 44 (05) :681-688

[8] The role of aminoglycosides in combination with a β-lactam for the treatment of bacterial endocarditis:: a meta-analysis of comparative trials [J].

Falagas, ME ;

Matthaiou, DK ;

Bliziotis, IA .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2006, 57 (04) :639-647

[9] Heterogeneous resistance to vancomycin in Staphylococcus epidermidis, Staphylococcus haemolyticus and Staphylococcus warneri clinical strains:: characterisation of glycopeptide susceptibility profiles and cell wall thickening [J].

Ferreira Nunes, Ana Paula ;

Teixeira, Lucia Martins ;

Pontes Iorio, Natalia Lopes ;

Reis Bastos, Carla Callegario ;

de Sousa Fonseca, Leila ;

Souto-Padron, Thais ;

Netto dos Santos, Katia Regina .

INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2006, 27 (04) :307-315

[10] Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility [J].

Hiramatsu, K ;

Hanaki, H ;

Ino, T ;

Yabuta, K ;

Oguri, T ;

Tenover, FC .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1997, 40 (01) :135-136

← 1 2 3 →